Ashajyothi C

Dr. Ashajyothi C

Biotechnology, Vijayanagara Sri Krishnadevaraya University, Bellary, India
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2016 in Journal of Nanostructure in Chemistry
Verified
Journal Article
Open access
PDF file
ACAshajyothi C
Ashajyothi C
Harish HandralHarish Handral
Harish Handral
Nileshkumar DubeyNileshkumar Dubey
Nileshkumar Dubey
KRKelmani Chandrakanth R
Kelmani Chandrakanth R
The synthesis of biogenic nanoparticles from non-chemical resources has increased the drive toward understanding infection biology. Accordingly, we aimed to address the symbiotic antibiofilm effect of biogenic copper and zinc oxide nanoparticles with antimicrobials against multidrug resistant (MDR) pathogens. The minimum inhibitory concentration (MIC) of copper nanoparticles (CuNPs) and zinc oxide nanoparticles (ZnONPs) at the range from 2 to 128 µg/ml was calculated against Gram-positive and Gram-negative pathogenic bacteria using a broth dilution method. Both nanoparticles have prime antibacterial activity compared with standard antibiotics (excluding against P.aeruginosa MTCC 741). A qualitative assessment of biofilm formation and collegial effect was performed using a modified test tube and the microtiter plate-based method by measuring the optical density and time kill of nanoparticles. The results demonstrated efficient antibiofilm activity of CuNPs in its lowest concentration than ZnONPs and antibiotics itself. In addition, significant enhancing antibiofilm effect was also shown by CuNPs in the presence of third generation antibiotics against Gram-negative and Gram-positive bacteria. A scanning electron microscopy (SEM) analysis was used to investigate the effect of the nanoparticles on morphological changes of Staphylococcus aureus. Current data highlights, biogenic CuNPs and ZnONPs could be used as an adjuvant for antibiotics in the treatment of bacterial infections.

26 September 2014 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
KRKelmani Chandrakanth R
Kelmani Chandrakanth R
ACAshajyothi C
Ashajyothi C
AOAjay Kumar Oli
Ajay Kumar Oli
PCPrabhurajeshwar C
Prabhurajeshwar C
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.

1 May 2016 in Environmental Nanotechnology, Monitoring & Management
Verified
Journal Article
Closed access
ACAshajyothi C
Ashajyothi C
PCPrabhurajeshwar C.
Prabhurajeshwar C.
Harish HandralHarish Handral
Harish Handral
CRChandrakanth Kelmani R.
Chandrakanth Kelmani R.

3 April 2018 in Discover Nano
Verified
Journal Article
Open access
PDF file
ACAshajyothi C
Ashajyothi C
Harish HandralHarish Handral
Harish Handral
KRKelmani Chandrakanth R
Kelmani Chandrakanth R
During the present time, anti-microbial features of copper (Cu) and zinc oxide (ZnO) nanoparticles (NPs) are extensively used to combat the growth of pathogenic microbes. CuNPs and ZnONPs are recurrently used in cosmetics, medicine and food additives, and their potential for toxic impacts on human and ecosystem is of high concern. In this study, the fate and toxicity of 16- to 96-nm-ranged biosynthesized copper (Bio-CuNPs) and zinc oxide (Bio-ZnONPs) was assessed in male Wistar rats. In vivo exposures of the two nanoparticles are achieved through two different administration routes namely, intraperitoneal (i/p) and intravenous (i/v) injections. The three different concentrations, no observable adverse effect concentration (NOAEC), inhibitory concentration (IC50) and total lethal concentration (TLC), were appraised at the dose range of 6.1 to 19.82 μg/kg and 11.14 to 30.3 μg/kg for Bio-CuNPs and Bio-ZnONPs respectively, for both i/p and i/v routes on 14th and 28th day of observation. These dose ranges are considered based on the previous study of antibacterial dose on multidrug-resistant pathogenic bacteria. In this study, we investigated the toxic effect of Bio-CuNPs and Bio-ZnONPs on animal behaviour, animal mass, haematologic indices, organ indices and histopathology of liver, spleen, kidney and brain organs. We found that i/v and i/p administration of Bio-ZnONPs in three different doses did not cause mortality and body weight was slightly reduced up to second week of administration compared with the vehicle control group. At the dose ranges of 11–16 μg/kg (i/v) and 24–30 μg/kg (i/p), no significant changes were observed in the serum creatinine level as well as serum ALT, serum AST level and ALP level which were 40.7 mg/dl, 37.9 IU/L and 82.4 IU/L normal as compared to vehicle control on 14th and 28th day of observation. These findings are confirmed in liver, kidney and spleen indices and histopathology studies. Furthermore, liver and kidney injury occurred when the concentrations of Bio-CuNPs were at 9.5 μg/kg (IC50) and 11.7 μg/kg (TLC) for i/v route of administration. Similarly, increase in serum ALT (67.7 mg/dl), AST level (70 IU/L) and ALP (128 IU/L) was also observed. And the body weight was significantly lower than in the control group after 14th day, and there were statistically significant differences observed by this route; interestingly, the toxicity of Bio-CuNPs in serum is prolonged (up to 28th day). Effect of Bio-CuNPs through i/p route was considerably low as compare to the control. Results of the present study revealed that Bio-ZnONPs have no effect on kidney and liver function biomarkers (both i/v and i/p) as compared to Bio-CuNPs. Graphical abstract As shown in graphical abstract (Fig. 1), our aim is to assess the toxicity of Bio-CuNPs and Bio-ZnONPs through in vivo protocol. According to Kahru and Dubourguier reviews, AgNPs, CuNPs and ZnONPs have been historically used as biocides, for preventing the growth of microorganisms and algae (Kahru and Dubourguier 2010). Therefore, as like pesticides, nanomaterials should be monitored for their toxic response toward non-target species, including humans and animals. To gain a better understanding whether the accidental release of metal-containing NPs may pose a threat to non-target species, assessing of toxic effect is indispensable.The ‘non-target organism’ is an organism which will be exposed to NPs after their incidental release into the environment.

19 January 2021 in Coatings
Verified
Journal Article
Open access
PDF file
Harish HandralHarish Handral
Harish Handral
ACAshajyothi C
Ashajyothi C
GSGopu Sriram
Gopu Sriram
KRKelmani Chandrakanth R
Kelmani Chandrakanth R
Nileshkumar DubeyNileshkumar Dubey
Nileshkumar Dubey
YCYing Chen
Ying Chen
Advances in the use of nanoparticles (NPs) has created promising progress in biotechnology and consumer-care based industry. This has created an increasing need for testing their safety and toxicity profiles. Hence, efforts to understand the cellular responses towards nanomaterials are needed. However, current methods using animal and cancer-derived cell lines raise questions on physiological relevance. In this aspect, in the current study, we investigated the use of pluripotent human embryonic stem cell- (hESCs) derived fibroblasts (hESC-Fib) as a closer representative of the in vivo response as well as to encourage the 3Rs (replacement, reduction and refinement) concept for evaluating the cytotoxic and genotoxic effects of zinc oxide (ZnO), titanium dioxide (TiO2) and silicon-dioxide (SiO2) NPs. Cytotoxicity assays demonstrated that the adverse effects of respective NPs were observed in hESC-Fib beyond concentrations of 200 µg/mL (SiO2 NPs), 30 µg/mL (TiO2 NPs) and 20 µg/mL (ZnO NPs). Flow cytometry results correlated with increased apoptosis upon increase in NP concentration. Subsequently, scratch wound assays showed ZnO (10 µg/mL) and TiO2 (20 µg/mL) NPs inhibit the rate of wound coverage. DNA damage assays confirmed TiO2 and ZnO NPs are genotoxic. In summary, hESC-Fib could be used as an alternative platform to understand toxicity profiles of metal oxide NPs.

1 January 2019 in Journal of Experimental Nanoscience
Verified
Journal Article
Open access
ACAshajyothi C
Ashajyothi C
KRKelmani Chandrakanth R
Kelmani Chandrakanth R
Toxic effects of nanoparticles on human health are considerably increasing their worldwide recognition. Currently silver nanoparticles are being widely used in consumer medical products, due to its uniqueness in biomedical applications. Uptake of these particles via various administration routes can also lead to different toxic effects. In this study, we assessed the toxic effect of 11–75 nm ranged biogenic silver nanoparticles (Bio-AgNPs) on male wistar rats by using two different administration routes namely, intraperitoneal and intravenous routes. The three different concentrations, No Observable Adverse Effect Concentration (NOAEC), Inhibitory concentration (IC50) and Total lethal concentration (TLC) was appraised at the dose range of 97.64 to 132 µg/kg for both i/p and i/v routes. There is no considerable changes in hematological parameters in i/p and i/v routes on 14th and 28th day of observation, but the increase was trivial significant for platelet count at the dose of 97–105 µg/kg (IC50) for i/p route of injection. There is no remarkable adverse impact on liver, spleen and kidney were observed in IC50 and TLC treated group, when determined by biochemical and histopathological analysis both in i/p and i/v routes treated rats. This estimation confirms that, Bio-AgNPs are not going effect the human metabolic system.